Matches in Nanopublications for { ?s ?p "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- NP384946.RA8qMOLCDJFfUYmsxThd5YA2-7Dacwl4uRUjLRZAw03h8130_assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384946.RA8qMOLCDJFfUYmsxThd5YA2-7Dacwl4uRUjLRZAw03h8130_provenance.
- NP51281.RA6ZLPQJAcy1x88Z8LEovIN3jKJ-fBVQjpZPYGQSlfkEw130_assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP51281.RA6ZLPQJAcy1x88Z8LEovIN3jKJ-fBVQjpZPYGQSlfkEw130_provenance.
- NP367378.RAEqy7o4tXd68k45G7XjBFrBPK7FSn_qFBnj8nlnCaLn0130_assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367378.RAEqy7o4tXd68k45G7XjBFrBPK7FSn_qFBnj8nlnCaLn0130_provenance.
- assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP419989.RATKbLhAD5fcAZ34Q5IT3lpYaVN8dd2OQSfs7bGWOmypQ130_assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419989.RATKbLhAD5fcAZ34Q5IT3lpYaVN8dd2OQSfs7bGWOmypQ130_provenance.
- NP821442.RAtYG-xjO-31DkY_zqbfrGJ4rC8ll3Uy598Jm4Q4X7PlA130_assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP821442.RAtYG-xjO-31DkY_zqbfrGJ4rC8ll3Uy598Jm4Q4X7PlA130_provenance.
- NP63725.RAzTYFFpCc7KwqULlojOui2ghGpC40vPKa1uqMp0VEDfs130_assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63725.RAzTYFFpCc7KwqULlojOui2ghGpC40vPKa1uqMp0VEDfs130_provenance.
- NP285153.RA4muUJUH8hTQi_b8GbJGhcu7M3aNIVppt1kUQ10oZZ9E130_assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285153.RA4muUJUH8hTQi_b8GbJGhcu7M3aNIVppt1kUQ10oZZ9E130_provenance.
- NP882040.RAFSjIswcWR9ASYyFQPbejf9g71axy8LNgOk1DON5anX8130_assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882040.RAFSjIswcWR9ASYyFQPbejf9g71axy8LNgOk1DON5anX8130_provenance.
- NP419991.RAKApZpiqlrljx-ohoRtDQaTcmJkOhc-irosG3fSzZEis130_assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419991.RAKApZpiqlrljx-ohoRtDQaTcmJkOhc-irosG3fSzZEis130_provenance.
- NP82464.RA4fZFFp9G9__MmJ4fgGxrFUWRVx4iFrQ6RdVYc7BKUtE130_assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82464.RA4fZFFp9G9__MmJ4fgGxrFUWRVx4iFrQ6RdVYc7BKUtE130_provenance.
- NP419990.RA-AYPd-OwaJCPkkbxbgX-0T_j_dqv4PSoHLOTWfj_SBY130_assertion description "[A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP419990.RA-AYPd-OwaJCPkkbxbgX-0T_j_dqv4PSoHLOTWfj_SBY130_provenance.